Thai Cancer Anemia Survey in Chulalongkorn Hospital

The purpose of this study is to create a large Thailand database documenting the severity of anemia and its management in the cancer population.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Anemia Cancer Hematologic Diseases Hemic and Lymphatic Diseases Neoplasms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Bangkok, Thailand

About this study

Thai Cancer Anemia Study (TCAS) is a prospective survey that will track anemia management in an adult cancer population. This survey is not intended to interfere with standard medical practices for handling anemia. Information on laboratory values including target and achieved hemoglobin (Hb) levels during chemotherapy cycles, use of blood transfusions, iron supplementation, and epoetin will be collected in addition to information on cancer status and treatment. Data on the level that triggers clinicians to decide on the need for anemia therapy will also be collected. Each patient included in the survey will be followed for six months. Observational Study - No investigational drug administered

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients with cancer

Exclusion criteria

None

Treatment and study plan

Adult Cancer Patients

Other

Tracking anemia management in Adult Cancer Patients

Primary outcomes

Number of patients that have anemia during cancer therapy

Time frame: 6 months

Secondary outcomes

Characteristic of each patients example treatment duration,type and chemotherapy using, grade of anemia

Time frame: 6 months

Sponsors and collaborators

Lead sponsor

Janssen-Cilag Ltd.,Thailand

Industry

Registry information

Important dates

Study start: 2006
Primary completion: 2009
Study completion: 2009
First posted: Nov 23, 2009
Registry last updated: May 23, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed